Chałaśkiewicz et al. reported that the histone deacetylase inhibitor Trichostatin A upregulates SNAI1 and SNAI2 expression, resulting in suppression of SLC2A5 (GLUT5) expression in colon cancer cells and consequently enhancing their sensitivity to chemotherapeutic agents cisplatin and oxaliplatin 142. Here, SLC2A5 is linked to malignant colon neoplasm.